It is commonly believed that primary insulin resistance, when associated with visceral obesity, is compensated for by increased insulin secretion and reduced insulin clearance; the latter serves to limit compensatory insulin release and prolong the life/function of the β-cell[47]. The gene discussed is INS; the disease is Insulin resistance.